Transforming growth factor beta in serum and bronchoalveolar lavage of COPD patients

E. Surkova, N. Kuzubova, T. Ses, A. Totolian (Saint-Petersburg, Russian Federation)

Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma
Session: Molecular pathogenesis: focus on COPD and asthma
Session type: Electronic Poster Discussion
Number: 503
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Surkova, N. Kuzubova, T. Ses, A. Totolian (Saint-Petersburg, Russian Federation). Transforming growth factor beta in serum and bronchoalveolar lavage of COPD patients. Eur Respir J 2007; 30: Suppl. 51, 503

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Elevated transforming growth factor (TGF)-β1 and thrombospondin (TSP)-1 levels in bronchoalveolar lavage (BAL) fluid of patients with pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 83s
Year: 2003

Epidermal growth factor in paediatric bronchoalveolar lavage fluid
Source: Eur Respir J 2004; 24: Suppl. 48, 271s
Year: 2004

Level of Transforming Growth Factor-β in bronchoalveolar lavage fluid after lung transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002

Levels of tumour necrosis factor and interferon in bronchoalveolar lavage fluid and blood serum in children with chronic bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 530s
Year: 2001

Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002

Insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in serum and bronchoalveolar lavage fluid of patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 469s
Year: 2004

Interleukin-1β and interleukin -1 receptor antagonist in serum and bronchoalveolar lavage of patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 746s
Year: 2006

Insulin-like growth factor-1 in idiopathic pulmonary fibrosis bronchoalveolar lavage fluid protects lung fibroblasts from apoptosis
Source: Eur Respir J 2001; 18: Suppl. 33, 358s
Year: 2001

Enhanced expression of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-6 in bronchoalveolar lavage cells from patients with sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 410s
Year: 2001

Measurement of trefoil factor peptides in bronchioalveolar lavage (BAL) fluids from patients with COPD or pulmonary cancer
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009

An indicative role of serum transforming growth factor-beta 1 (TGF-β1) level on the determination of clinical severity of pulmonary tuberculosis
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005


Platelet-derived growth factor levels in sputum of patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 423s
Year: 2002

Transforming growth factor β in induced sputum and whole blood in cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


Angiogenetic profiles (VEGF and VEGF receptor-1, Flt-1) in bronchoalveolar lavage fluid in patients with interstitial lung diseases
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008

A study on interleukin-8 and monokine induced by interferon gamma in serum and bronchoalveolar lavage of critically ill children with interstitial lung disease
Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Year: 2008


A mobile fibroblast phenotype in human bronchoalveolar lavage fluid from asthmatic subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 695s
Year: 2004

Release of TGF β from sputum cell culture in COPD and asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 673s
Year: 2006

Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF)
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009

Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Matrix metalloproteinase-9 (MMP-9) and transforming growth factor β1 (TGF β1) levels in induced sputum and serum samples of mild and severe asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 163s
Year: 2001